Douglas J Swirsky
CIK 1375884 · CHIEF FINANCIAL OFFICER · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$159.5K
Companies
8
Total Filings
56
Lifetime Open-Market Net
$206.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLRB | Director | 83 | $2.50 | $208 | $26.0K | 7 | 2026-07-08 |
| MXCT | CHIEF FINANCIAL OFFICER | 151,669 | $1.05 | $159.3K | $34.2K | 6 | 2026-03-19 |
| MetaVia Inc. (NRBO) Delisted | Director | — | $2.36 | — | $0 | 1 | 2020-09-03 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Director | — | $0.12 | — | $0 | 4 | 2020-06-25 |
| Fibrocell Science, Inc. (FCSC) Delisted | Director | — | — | — | $0 | 7 | 2019-12-13 |
| Opus Genetics, Inc. (RNN) Delisted | President and CEO | 4,167 | — | — | $31.7K | 3 | 2019-01-30 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | — | — | — | $0 | 2 | 2018-05-23 |
| GENVEC INC (GNVC) Delisted | President & CEO | 25,250 | — | — | $114.1K | 20 | 2016-09-16 |
Recent Filings · Page 4 of 6
56 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-01 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-15 | GENVEC INC (GNVC) Delisted | Buy (P) | +5,000 | $10.0K | EDGAR |
| 2015-08-07 | GENVEC INC (GNVC) Delisted | Buy (P) | +5,500 | $10.4K | EDGAR |
| 2015-06-25 | Fibrocell Science, Inc. (FCSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-16 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-15 | GENVEC INC (GNVC) Delisted | Grant (A) | +5,500 | $10.4K | EDGAR |
| 2014-01-24 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-09-05 | GENVEC INC (GNVC) Delisted | Grant (A) | +200,000 | $0 | EDGAR |
| 2013-07-23 | Fibrocell Science, Inc. (FCSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-05 | — | Grant (A) | — | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.